Novopharma

Novopharma Pharmaceutical Industries is a prominent pharmaceutical manufacturing company based in the United Arab Emirates, specializing in the development and production of high-quality generic and branded generic medicines. Established in 2003, the company operates a state-of-the-art manufacturing facility in Ras Al Khaimah that adheres to international Good Manufacturing Practice (GMP) standards. Its diverse product portfolio spans multiple therapeutic areas, including cardiovascular health, anti-infectives, central nervous system disorders, and metabolic diseases. Novopharma serves both the domestic UAE market and various international markets across the Middle East and Africa. The company is recognized for its commitment to providing affordable healthcare solutions through robust manufacturing capabilities and strategic regional partnerships.